mirikizumab
General
Pronunciation:
mir-i-kiz-ue-mab
Trade Name(s)
- Omvoh
Ther. Class.
gastrointestinal anti-inflammatories
Pharm. Class.
interleukin antagonists
monoclonal antibodies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Mirikizumab." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580219/all/mirikizumab.
Vallerand AHA, Sanoski CAC. Mirikizumab. Davis's Drug Guide. F.A. Davis Company; 2026. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580219/all/mirikizumab. Accessed October 23, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Mirikizumab. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580219/all/mirikizumab
Vallerand AHA, Sanoski CAC. Mirikizumab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 October 23]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580219/all/mirikizumab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - mirikizumab
ID - 3580219
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580219/all/mirikizumab
PB - F.A. Davis Company
ET - 20
DB - Nursing Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

